{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:48:28Z","timestamp":1780598908674,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordination for the Improvement of Higher Education Personnel","doi-asserted-by":"crossref","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s10067-021-05654-2","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T23:02:45Z","timestamp":1614207765000},"page":"3833-3839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Adalimumab-induced sarcoidosis-like reaction involving oral cavity in rheumatoid arthritis: a case-based review"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1290-6235","authenticated-orcid":false,"given":"Carla Isabelly","family":"Rodrigues-Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2535-2606","authenticated-orcid":false,"given":"Cesar Augusto","family":"Migliorati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4979-4318","authenticated-orcid":false,"given":"Luiz Alcino Monteiro","family":"Gueiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2997-8016","authenticated-orcid":false,"given":"Thayn\u00e1 Melo","family":"de Lima Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-4911","authenticated-orcid":false,"given":"Pablo Agustin","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2002-8003","authenticated-orcid":false,"given":"Oslei Paes","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6677-0065","authenticated-orcid":false,"given":"M\u00e1rcio Ajudarte","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2040-6617","authenticated-orcid":false,"given":"Alan Roger","family":"Santos-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"5654_CR1","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, M\u00fcller-Quernheim J (2014) Sarcoidosis. Lancet. 383:1155\u20131167","journal-title":"Lancet."},{"key":"5654_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccm.2015.08.002","volume":"36","author":"TE Fingerlin","year":"2015","unstructured":"Fingerlin TE, Hamzeh N, Maier LA (2015) Genetics of sarcoidosis. Clin chest Med. 36:569\u2013584","journal-title":"Clin chest Med."},{"key":"5654_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.mcna.2018.12.011","volume":"104","author":"O Llanos","year":"2019","unstructured":"Llanos O, Hamzeh N (2019) Sarcoidosis. Med Clin N Am. 104:527\u2013534","journal-title":"Med Clin N Am."},{"key":"5654_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/qjmed\/hcs042","volume":"105","author":"J Bouaziz","year":"2012","unstructured":"Bouaziz J, Le Scanff C, Chapelon-Abric L et al (2012) Oral involvement in sarcoidosis: report of 12 cases. Q J Med. 105:755\u2013767","journal-title":"Q J Med."},{"key":"5654_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.chest.2018.02.003","volume":"154","author":"WE James","year":"2018","unstructured":"James WE, Koutroumpakis E, Saha B, Nathani A, Saavedra L, Yucel RM, Judson MA (2018) Clinical features of extrapulmonary sarcoidosis without lung involvement. Chest. 154:349\u2013356","journal-title":"Chest."},{"key":"5654_CR6","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/DAD.0b013e3181af21b6","volume":"32","author":"A Martorell-Calatayud","year":"2010","unstructured":"Martorell-Calatayud A, Balmer N, Cardona LFC, Teague D (2010) Interstitial granulomatous drug reaction to adalimumab. Am J Dermatopathol. 32:408\u2013409","journal-title":"Am J Dermatopathol."},{"issue":"1","key":"5654_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","volume":"5","author":"J Grunewald","year":"2019","unstructured":"Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, M\u00fcller-Quernheim J (2019) Sarcoidosis. Nat Rev Dis Primers 5(1):45","journal-title":"Nat Rev Dis Primers"},{"key":"5654_CR8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.chest.2018.03.056","volume":"154","author":"A Chopra","year":"2018","unstructured":"Chopra A, Nautiyal A, Kalkanis A, Judson MA (2018) Drug-induced sarcoidosis-like reactions. Chest. 154:664\u2013677","journal-title":"Chest."},{"key":"5654_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/joim.13008","volume":"288","author":"MA Judson","year":"2019","unstructured":"Judson MA (2019) The epidemic of drug-induced sarcoidosis-like reactions: a side effect that we can live with. J Intern Med. 288:373\u2013375. https:\/\/doi.org\/10.1111\/joim.13008","journal-title":"J Intern Med."},{"key":"5654_CR10","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/joim.12991","volume":"288","author":"FC Aubart","year":"2019","unstructured":"Aubart FC, Lhote R, Amoura A, Valeyre D et al (2019) Drug-induced sarcoidosis: an overview of the WHO pharmacovigilance database. J Intern Med. 288:356\u2013362. https:\/\/doi.org\/10.1111\/joim.12991","journal-title":"J Intern Med."},{"key":"5654_CR11","first-page":"53","volume":"10","author":"S Bhargava","year":"2013","unstructured":"Bhargava S, Perlman DM, Allen TL, Ritter JH, Bhargava M (2013) Adalimumab induced pulmonary sarcoid reaction. Respir Med Case Rep 10:53\u201355","journal-title":"Respir Med Case Rep"},{"key":"5654_CR12","first-page":"126","volume":"22","author":"M Al-Dliw","year":"2017","unstructured":"Al-Dliw M, Megri M, Shahoub I, Sahay G, Limjoco TI, Shweihat Y (2017) Pembrolizumab reactivates pulmonary granulomatosis. Respir Med Case Rep 22:126\u2013129","journal-title":"Respir Med Case Rep"},{"key":"5654_CR13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5021\/ad.2017.29.1.74","volume":"29","author":"SK Park","year":"2017","unstructured":"Park SK, Hwang PH, Yun SK, Kim HU, Park J (2017) Tumor necrosis factor alpha blocker-induced erythrodermic sarcoidosis in with juvenile rheumatoid arthritis: a case report and review of the literature. Ann Dermatol 29:74\u201378","journal-title":"Ann Dermatol"},{"key":"5654_CR14","doi-asserted-by":"publisher","first-page":"476955","DOI":"10.1016\/j.jneuroim.2019.04.015","volume":"333","author":"R Durcan","year":"2019","unstructured":"Durcan R, Heffron C, Sweeney B (2019) Natalizumab induced cutaneous sarcoidosis-like reaction. J Neuroimmunol 333:476955","journal-title":"J Neuroimmunol"},{"key":"5654_CR15","doi-asserted-by":"crossref","unstructured":"Mobini N, Dhillon R, Dickey J, Spoon J, Sadrolashrafi K (2019) Exclusive cutaneous and subcutaneous sarcoidal granulomatous inflammation due to immune checkpoint inhibitors: report of two cases with unusual manifestations and review of the literature. Case Rep Dermatol Med 6702870","DOI":"10.1155\/2019\/6702870"},{"key":"5654_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10067-010-1603-3","volume":"30","author":"T Kanellopoulou","year":"2011","unstructured":"Kanellopoulou T, Filiotou A, Kranidioti H, Dourakis SP (2011) Sarcoid-like granulomatosis in patients treated with anti-TNF\u03b1 factors. A case report and review of the literature. Clin Rheumatol 30:581\u2013583","journal-title":"Clin Rheumatol"},{"key":"5654_CR17","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/rheumatology\/ker166","volume":"50","author":"J Salvatierra","year":"2011","unstructured":"Salvatierra J, Magro-Checa C, Rosales-Alexander JL, Raya-Alvarez E (2011) Acute sarcoidosis as parotid fever in rheumatoid arthritis under anti-tumor necrosis factor-alpha therapy. Rheumatology (Oxford) 50:1346\u20131348","journal-title":"Rheumatology (Oxford)"},{"key":"5654_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1471-2377-13-212","volume":"13","author":"CA Durel","year":"2013","unstructured":"Durel CA, Feurer E, Pialat JB, Berthoux E, Chapurlat RD, Confavreux CB (2013) Etanercept May induce neurosarcoidosis in a patient treated for rheumatoid arthritis. BMC Neurol. 13:212","journal-title":"BMC Neurol."},{"key":"5654_CR19","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.5114\/aoms.2014.47827","volume":"10","author":"K Lis","year":"2014","unstructured":"Lis K, Kuzawi\u0144ska O, Ba\u0142kowiec-Iskra E (2014) Tumor necrosis factor inhibitors\u2014state of knowledge. Arch Med Sci. 10:1175\u20131178","journal-title":"Arch Med Sci."},{"key":"5654_CR20","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1186\/ar4615","volume":"16","author":"C Zamora-Atenza","year":"2014","unstructured":"Zamora-Atenza C, Diaz-Torne C, Geli C, Diaz-Lopez C, Ortiz MA, Moya P, Castellv\u00ed I, Nieto JC, Cant\u00f3 E, Casademont J, Juarez C, Llobet JM, Vidal S (2014) Adalimumab regulates intracellular TNF\u03b1 production in patients with rheumatoid arthritis. Arthritis Res Ther. 16:R153","journal-title":"Arthritis Res Ther."},{"key":"5654_CR21","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1111\/jdv.13246","volume":"29","author":"KT Amber","year":"2015","unstructured":"Amber KT, Bloom R, Mrowietz U, Hertl M (2015) TNF-\u03b1: A treatment target or cause of sarcoidosis? J Eur Acad Dermatol Venereol. 29:2104\u20132111","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"5654_CR22","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/bcp.13494","volume":"84","author":"O Gendelman","year":"2018","unstructured":"Gendelman O, Weitzman D, Rosenberg V, Shalev V, Chodick G, Amital H (2018) Characterization of adherence and persistence profile in a real-life population of patients treated with adalimumab. Br J Clin Pharmacol. 84:786\u2013795","journal-title":"Br J Clin Pharmacol."},{"key":"5654_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Mu\u00f1oz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86:242\u2013251","journal-title":"Medicine (Baltimore)"},{"key":"5654_CR24","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nrgastro.2012.125","volume":"9","author":"I Cleynen","year":"2012","unstructured":"Cleynen I, Vermeire S (2012) Paradoxical inflammation induced by anti-TNF agents in patients with IBD. Nat Rev Gastroenterol Hepatol. 9:496\u2013503","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"5654_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/1744666X.2014.866038","volume":"10","author":"D Wendling","year":"2014","unstructured":"Wendling D, Prati C (2014) Paradoxical effects of anti-TNF-\u03b1 agents in inflammatory diseases. Expert Rev Clin Immunol. 10:159\u2013169","journal-title":"Expert Rev Clin Immunol."},{"key":"5654_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.semarthrit.2008.11.003","volume":"39","author":"A Massara","year":"2010","unstructured":"Massara A, Cavazzini L, La Corte R, Trotta F (2010) Sarcoidosis appearing during anti-tumor necrosis factor alpha therapy: a new \u201cclass effect\u201d paradoxical phenomenon. Two case reports and literature review. Semin Arthritis Rheum. 39:313\u2013319","journal-title":"Semin Arthritis Rheum."},{"key":"5654_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.amjoto.2012.12.016","volume":"34","author":"A Christoforidou","year":"2013","unstructured":"Christoforidou A, Goudakos J, Bobos M, Lefkaditis E, Vital V, Markou K (2013) Sarcoidosis-like granulomatosis of the hypopharynx as a complication of anti-TNF therapy. Am J Otolaryngol. 34:268\u2013272","journal-title":"Am J Otolaryngol."},{"key":"5654_CR28","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 151:264\u2013269","journal-title":"Ann Intern Med."}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05654-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-021-05654-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-021-05654-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T09:10:21Z","timestamp":1628673021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-021-05654-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["5654"],"URL":"https:\/\/doi.org\/10.1007\/s10067-021-05654-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"assertion":[{"value":"8 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}